Cargando…

Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic

Mostrar otras versiones (1)

BACKGROUND: Coronavirus disease 2019 (COVID-19) is associated with provoked thrombo-inflammatory responses. Early in the COVID-19 pandemic this was thought to contribute to hypercoagulability and multi-organ system complications in infected patients. Limited studies have evaluated the impact of ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaghloul, Mohamed S., Jammeh, Momodou, Gibson, Andrew, Luo, Suhong, Chadwick-Mansker, Kelley, Liu, Qianjin, Yan, Yan, Zayed, Mohamed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885912/ https://www.ncbi.nlm.nih.gov/pubmed/36717941 http://dx.doi.org/10.1186/s12959-023-00460-z

Ejemplares similares

Chronic Anti-Coagulation Therapy Reduced Mortality In Patients With High Cardiovascular Risk Early In COVID-19 Pandemic
por: Zaghloul, Mohamed S., et al.
Publicado: (2022)

Outpatient Chronic Anticoagulation Improves Outcomes in Patients With Coronavirus Disease 2019 and Cardiovascular Risk Factors
por: Gibson, Andrew K., et al.
Publicado: (2021)

Modified bare-back micro-retrograde tibial arterial access to facilitate peripheral endovascular therapy
por: Gani, Faiz, et al.
Publicado: (2023)

Reoperative Brachial Plexus Neurolysis After Previous Anatomically Complete Supraclavicular Decompression for Neurogenic Thoracic Outlet Syndrome: A 10-Year Single-Center Case Series
por: Jammeh, Momodou L., et al.
Publicado: (2022)

Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection
por: Pincus, Nathan B., et al.
Publicado: (2015)

Quantifying excess mortality during the COVID-19 pandemic in 2020 in The Gambia: a time-series analysis of three health and demographic surveillance systems
por: Mohammed, Nuredin I., et al.
Publicado: (2023)

Analysis of prognostic factors for in-hospital mortality in patients with unplanned re-exploration after cardiovascular surgery
por: Deng, Jianying, et al.
Publicado: (2022)

THROMBOSIS AND ANTI-COAGULANT THERAPY
Publicado: (1961)

Heparin beyond anti-coagulation
por: Chen, Daohong
Publicado: (2021)

Are Reduced Levels of Coagulation Proteins Upon Admission Linked to COVID-19 Severity and Mortality?
por: Ceballos, Francisco C., et al.
Publicado: (2021)

The Association of Coagulation Indicators and Coagulant Agents With 30-Day Mortality of Critical Diabetics
por: Huang, Yingxin, et al.
Publicado: (2021)

Outcomes in COVID-19 Patients on Treatment Dose Anti-Coagulation Compared to Prophylactic Dose Anti-Coagulation
por: Kodama, Rich, et al.
Publicado: (2020)

Examining Disparities and Excess Cardiovascular Mortality Before and During the COVID-19 Pandemic
por: Janus, Scott E., et al.
Publicado: (2022)

The Interface between Inflammation and Coagulation in Cardiovascular Disease
por: Demetz, Gabriele, et al.
Publicado: (2012)

The utility of coagulation activity for prediction of risk of mortality and cardiovascular events in guideline-treated myocardial infarction patients
por: Christersson, Christina, et al.
Publicado: (2017)

REDucing Unnecessary Coagulation Testing in the Emergency Department (REDUCED)
por: Fralick, Michael, et al.
Publicado: (2017)

Update on anti-coagulation in atrial fibrillation
por: Kreuzer, J.
Publicado: (2011)

Phospholipase A2 enzyme from the venom of Egyptian honey bee Apis mellifera lamarckii with anti-platelet aggregation and anti-coagulation activities
por: Darwish, Doaa A., et al.
Publicado: (2021)

Trends of Coagulation Parameters in Human Immunodeficiency Virus Patients
por: Bashir, Bashir Abdrhman, et al.
Publicado: (2023)

Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
por: Duprez, Daniel A., et al.
Publicado: (2012)

Determining the anti-coagulant-independent anti-cancer effects of heparin
por: Solari, V, et al.
Publicado: (2010)

Aldosterone Antagonists Reduce the Risk of Cardiovascular Mortality in Dialysis Patients: A Meta-Analysis
por: Li, Yan, et al.
Publicado: (2019)

FREEZING POINTS OF ANTI-COAGULANT SALT SOLUTIONS
por: Hitchcock, David I., et al.
Publicado: (1935)

Tackling anti-coagulation under-prescription in the elderly
por: Fawzy, Ameenathul M., et al.
Publicado: (2019)

The Antioxidant, Anti-Platelet and Anti-Coagulant Properties of Phenolic Compounds, Associated with Modulation of Hemostasis and Cardiovascular Disease, and Their Possible Effect on COVID-19
por: Olas, Beata
Publicado: (2022)

Considerable Production of Ulvan from Ulva lactuca with Special Emphasis on Its Antimicrobial and Anti-fouling Properties
por: Ibrahim, Mohamed I. A., et al.
Publicado: (2022)

Totally percutaneous endovascular repair for ruptured abdominal aortic aneurysms
por: Tay, Shirli, et al.
Publicado: (2022)

Profile of bioactive compounds in Nymphaea alba L. leaves growing in Egypt: hepatoprotective, antioxidant and anti-inflammatory activity
por: Bakr, Riham Omar, et al.
Publicado: (2017)

Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection
por: Kuller, Lewis H, et al.
Publicado: (2008)

Association of Blood Glucose Variability with Sepsis-Related Disseminated Intravascular Coagulation Morbidity and Mortality
por: Liu, Dan, et al.
Publicado: (2022)

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
por: Paar, Vera, et al.
Publicado: (2020)

Coagulation Inhibitors in COVID-19 Leading to Compressive Airway Hematoma
por: Mohamed, Amr
Publicado: (2021)

Implementation of breast cancer continuum of care in low- and middle-income countries during the COVID-19 pandemic
por: Elghazawy, Hagar, et al.
Publicado: (2020)

Characteristics of coagulation alteration in patients with COVID-19
por: Luo, Hong-chun, et al.
Publicado: (2020)

Ketosis Prevents Abdominal Aortic Aneurysm Rupture Through C-C Chemokine Receptor Type 2 Downregulation and Enhanced MMP Balance
por: Zayed, Mohamed, et al.
Publicado: (2023)

Progress in reducing inequalities in cardiovascular disease mortality in Europe
por: Di Girolamo, Chiara, et al.
Publicado: (2020)

Before and during the COVID-19 Pandemic, Physical Fitness Association with Mental Health among Higher Education Students: A Multi-Group Analysis Model
por: Elshaer, Ibrahim A., et al.
Publicado: (2022)

Gene variants in pro-coagulant and anti-coagulant genes could be prognostic genetic markers of COVID-19 susceptibility
por: Srivastava, Swati, et al.
Publicado: (2022)

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients
por: Zhang, Yan, et al.
Publicado: (2020)

Associations between coagulation factor XII, coagulation factor XI, and stability of venous thromboembolism: A case-control study
por: Meng, Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fle0p6tiaic1hbpqvgmfood6qu